These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
90-0199783
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
1275 Market Street
San Francisco, CA
|
94103-1410
|
(415) 558-0200
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(Registrant’s telephone number, including area code)
|
|
Large accelerated filer
ý
|
|
Accelerated filer
¨
|
|
Non-accelerated filer
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
¨
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
||
|
Abbreviation
|
|
Term
|
|
AAC
|
|
Advanced Audio Coding
|
|
AOCI
|
|
Accumulated Other Comprehensive Income
|
|
APIC
|
|
Additional-Paid In-Capital
|
|
ASP
|
|
Average Selling Price
|
|
ASU
|
|
Accounting Standards Update
|
|
ATSC
|
|
Advanced Television Systems Committee
|
|
AVR
|
|
Audio/Video Receiver
|
|
CODM
|
|
Chief Operating Decision-Maker
|
|
COGS
|
|
Cost Of Goods Sold
|
|
COSO
|
|
Committee Of Sponsoring Organizations (Of The Treadway Commission)
|
|
DCI
|
|
Digital Cinema Initiative
|
|
DD
|
|
Dolby Digital®
|
|
DD+
|
|
Dolby Digital Plus™
|
|
DMA
|
|
Digital Media Adapter
|
|
DTV
|
|
Digital Television
|
|
DVB
|
|
Digital Video Broadcasting
|
|
DVD
|
|
Digital Versatile Disc
|
|
EPS
|
|
Earnings Per Share
|
|
ESP
|
|
Estimated Selling Price
|
|
ESPP
|
|
Employee Stock Purchase Plan
|
|
FASB
|
|
Financial Accounting Standards Board
|
|
FCPA
|
|
Foreign Corrupt Practices Act
|
|
G&A
|
|
General & Administrative
|
|
GAAP
|
|
Generally Accepted Accounting Principles
|
|
HDR
|
|
High Dynamic Range
|
|
HDTV
|
|
High Definition Television
|
|
HE AAC
|
|
High Efficiency Advanced Audio Coding
|
|
HEVC
|
|
High Efficiency Video Coding
|
|
HFR
|
|
High Frame Rate
|
|
HTIB
|
|
Home Theater In-A-Box
|
|
IC
|
|
Integrated Circuit
|
|
IMB
|
|
Integrated Media Block
|
|
IPO
|
|
Initial Public Offering
|
|
IPTV
|
|
Internet Protocol Television
|
|
ISO
|
|
Incentive Stock Option
|
|
ISV
|
|
Independent Software Vendor
|
|
IT
|
|
Information Technology
|
|
LCD
|
|
Liquid Crystal Display
|
|
LP
|
|
Limited Partner/Partnership
|
|
ME
|
|
Multiple Element
|
|
NATO
|
|
North American Theatre Owners
|
|
NOL
|
|
Net Operating Loss
|
|
NQ
|
|
Non-Qualified/Non-Statutory Stock Option
|
|
OCI
|
|
Other Comprehensive Income
|
|
ODD
|
|
Optical Disc Drive
|
|
OECD
|
|
Organization For Economic Co-Operation & Development
|
|
OEM
|
|
Original Equipment Manufacturer
|
|
OLED
|
|
Organic Light-Emitting Diode
|
|
OTT
|
|
Over-The-Top
|
|
PC
|
|
Personal Computer
|
|
PCS
|
|
Post-Contract Support
|
|
PP&E
|
|
Property, Plant And Equipment
|
|
PSO
|
|
Performance-Based Stock Option
|
|
R&D
|
|
Research & Development
|
|
RSU
|
|
Restricted Stock Unit
|
|
S&M
|
|
Sales & Marketing
|
|
SAR
|
|
Stock Appreciation Rights
|
|
SERP
|
|
Supplemental Executive Retirement Plan
|
|
SoC
|
|
System-On-A-Chip
|
|
STB
|
|
Set-Top Box
|
|
TAM
|
|
Total Available Market
|
|
TPE
|
|
Third Party Evidence
|
|
TSR
|
|
Total Stockholder Return
|
|
UHD
|
|
Ultra High Definition
|
|
U.S. GAAP
|
|
Generally Accepted Accounting Principles In The United States
|
|
VSOE
|
|
Vendor Specific Objective Evidence
|
|
|
April 1,
2016 |
September 25,
2015 |
||||
|
ASSETS
|
(unaudited)
|
|
||||
|
Current assets:
|
|
|
||||
|
Cash and cash equivalents
|
$
|
521,202
|
|
$
|
531,926
|
|
|
Restricted cash
|
5,278
|
|
2,936
|
|
||
|
Short-term investments
|
104,267
|
|
138,901
|
|
||
|
Accounts receivable, net of allowance for doubtful accounts of $2,665 and $1,542
|
102,083
|
|
101,563
|
|
||
|
Inventories
|
17,259
|
|
13,872
|
|
||
|
Prepaid expenses and other current assets
|
36,198
|
|
32,031
|
|
||
|
Total current assets
|
786,287
|
|
821,229
|
|
||
|
Long-term investments
|
268,091
|
|
321,015
|
|
||
|
Property, plant and equipment, net
|
416,254
|
|
403,091
|
|
||
|
Intangible assets, net
|
216,082
|
|
127,507
|
|
||
|
Goodwill
|
309,880
|
|
307,708
|
|
||
|
Deferred taxes
|
149,272
|
|
143,279
|
|
||
|
Other non-current assets
|
12,985
|
|
9,464
|
|
||
|
Total assets
|
$
|
2,158,851
|
|
$
|
2,133,293
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
||||
|
Current liabilities:
|
|
|
||||
|
Accounts payable
|
$
|
17,632
|
|
$
|
20,710
|
|
|
Accrued liabilities
|
158,534
|
|
169,307
|
|
||
|
Income taxes payable
|
—
|
|
754
|
|
||
|
Deferred revenue
|
22,321
|
|
18,910
|
|
||
|
Total current liabilities
|
198,487
|
|
209,681
|
|
||
|
Long-term deferred revenue
|
35,652
|
|
30,581
|
|
||
|
Other non-current liabilities
|
70,664
|
|
77,024
|
|
||
|
Total liabilities
|
304,803
|
|
317,286
|
|
||
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
||||
|
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 53,265,096 shares issued and outstanding at April 1, 2016 and 50,291,426 at September 25, 2015
|
54
|
|
51
|
|
||
|
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 46,790,462 shares issued and outstanding at April 1, 2016 and 50,743,311 at September 25, 2015
|
47
|
|
51
|
|
||
|
Additional paid-in capital
|
—
|
|
17,571
|
|
||
|
Retained earnings
|
1,853,602
|
|
1,800,857
|
|
||
|
Accumulated other comprehensive (loss)
|
(8,342
|
)
|
(11,462
|
)
|
||
|
Total stockholders’ equity – Dolby Laboratories, Inc.
|
1,845,361
|
|
1,807,068
|
|
||
|
Controlling interest
|
8,687
|
|
8,939
|
|
||
|
Total stockholders’ equity
|
1,854,048
|
|
1,816,007
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
2,158,851
|
|
$
|
2,133,293
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
||||||||
|
Revenue:
|
|
|
|
|
|
||||||||
|
Licensing
|
$
|
249,336
|
|
$
|
243,333
|
|
|
$
|
460,465
|
|
$
|
459,931
|
|
|
Products
|
20,063
|
|
22,985
|
|
|
44,872
|
|
36,248
|
|
||||
|
Services
|
4,941
|
|
5,632
|
|
|
9,817
|
|
10,009
|
|
||||
|
Total revenue
|
274,340
|
|
271,950
|
|
|
515,154
|
|
506,188
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Cost of revenue:
|
|
|
|
|
|
||||||||
|
Cost of licensing
|
6,698
|
|
3,787
|
|
|
13,231
|
|
7,268
|
|
||||
|
Cost of products
|
13,978
|
|
18,237
|
|
|
33,016
|
|
30,821
|
|
||||
|
Cost of services
|
3,697
|
|
3,125
|
|
|
7,892
|
|
6,470
|
|
||||
|
Total cost of revenue
|
24,373
|
|
25,149
|
|
|
54,139
|
|
44,559
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Gross margin
|
249,967
|
|
246,801
|
|
|
461,015
|
|
461,629
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Operating expenses:
|
|
|
|
|
|
||||||||
|
Research and development
|
52,088
|
|
56,601
|
|
|
105,416
|
|
105,195
|
|
||||
|
Sales and marketing
|
71,815
|
|
65,940
|
|
|
146,269
|
|
133,958
|
|
||||
|
General and administrative
|
42,482
|
|
45,653
|
|
|
86,560
|
|
90,369
|
|
||||
|
Restructuring charges/(credits)
|
1,255
|
|
—
|
|
|
1,255
|
|
(39
|
)
|
||||
|
Total operating expenses
|
167,640
|
|
168,194
|
|
|
339,500
|
|
329,483
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Operating income
|
82,327
|
|
78,607
|
|
|
121,515
|
|
132,146
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Other income/expense:
|
|
|
|
|
|
||||||||
|
Interest income
|
1,250
|
|
1,091
|
|
|
2,547
|
|
1,991
|
|
||||
|
Interest expense
|
(33
|
)
|
(31
|
)
|
|
(62
|
)
|
(46
|
)
|
||||
|
Other income/(expense), net
|
279
|
|
218
|
|
|
(693
|
)
|
110
|
|
||||
|
Total other income
|
1,496
|
|
1,278
|
|
|
1,792
|
|
2,055
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income before income taxes
|
83,823
|
|
79,885
|
|
|
123,307
|
|
134,201
|
|
||||
|
Provision for income taxes
|
(16,278
|
)
|
(21,353
|
)
|
|
(24,751
|
)
|
(33,732
|
)
|
||||
|
Net income including controlling interest
|
67,545
|
|
58,532
|
|
|
98,556
|
|
100,469
|
|
||||
|
Less: net (income) attributable to controlling interest
|
(147
|
)
|
(558
|
)
|
|
(257
|
)
|
(1,138
|
)
|
||||
|
Net income attributable to Dolby Laboratories, Inc.
|
$
|
67,398
|
|
$
|
57,974
|
|
|
$
|
98,299
|
|
$
|
99,331
|
|
|
|
|
|
|
|
|
||||||||
|
Net Income Per Share:
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.67
|
|
$
|
0.57
|
|
|
$
|
0.98
|
|
$
|
0.97
|
|
|
Diluted
|
$
|
0.66
|
|
$
|
0.56
|
|
|
$
|
0.97
|
|
$
|
0.95
|
|
|
Weighted-Average Shares Outstanding:
|
|
|
|
|
|
||||||||
|
Basic
|
100,456
|
|
102,509
|
|
|
100,600
|
|
102,406
|
|
||||
|
Diluted
|
101,555
|
|
103,904
|
|
|
101,716
|
|
104,097
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Related party rent expense:
|
|
|
|
|
|
||||||||
|
Included in operating expenses
|
$
|
756
|
|
$
|
755
|
|
|
$
|
1,537
|
|
$
|
1,543
|
|
|
Included in net income attributable to controlling interest
|
$
|
174
|
|
$
|
1,151
|
|
|
$
|
350
|
|
$
|
2,304
|
|
|
|
|
|
|
|
|
||||||||
|
Cash dividend declared per common share
|
$
|
0.12
|
|
$
|
0.10
|
|
|
$
|
0.24
|
|
$
|
0.20
|
|
|
Cash dividend paid per common share
|
$
|
0.12
|
|
$
|
0.10
|
|
|
$
|
0.24
|
|
$
|
0.20
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
||||||||
|
Net income including controlling interest
|
$
|
67,545
|
|
$
|
58,532
|
|
|
$
|
98,556
|
|
$
|
100,469
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
||||||
|
Foreign currency translation adjustments, net of tax
|
2,872
|
|
(6,319
|
)
|
|
2,122
|
|
(11,872
|
)
|
||||
|
Unrealized gains on available-for-sale securities, net of tax
|
1,563
|
|
842
|
|
|
703
|
|
665
|
|
||||
|
Comprehensive income
|
71,980
|
|
53,055
|
|
|
101,381
|
|
89,262
|
|
||||
|
Less: comprehensive (income)/loss attributable to controlling interest
|
(1
|
)
|
(425
|
)
|
|
38
|
|
(477
|
)
|
||||
|
Comprehensive income attributable to Dolby Laboratories, Inc.
|
$
|
71,979
|
|
$
|
52,630
|
|
|
$
|
101,419
|
|
$
|
88,785
|
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
|
Common
Stock
|
Additional
Paid-In
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income/(Loss)
|
Total Dolby
Laboratories,
Inc.
|
Controlling
Interest
|
Total
|
||||||||||||||
|
Balance at September 25, 2015
|
$
|
102
|
|
$
|
17,571
|
|
$
|
1,800,857
|
|
$
|
(11,462
|
)
|
$
|
1,807,068
|
|
$
|
8,939
|
|
$
|
1,816,007
|
|
|
Net income
|
—
|
|
—
|
|
98,299
|
|
—
|
|
98,299
|
|
257
|
|
98,556
|
|
|||||||
|
Currency translation adjustments, net of tax of $188
|
—
|
|
—
|
|
—
|
|
2,417
|
|
2,417
|
|
(295
|
)
|
2,122
|
|
|||||||
|
Unrealized gains on investments, net of tax of $(17)
|
—
|
|
—
|
|
—
|
|
703
|
|
703
|
|
—
|
|
703
|
|
|||||||
|
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(214
|
)
|
(214
|
)
|
|||||||
|
Stock-based compensation expense
|
—
|
|
35,466
|
|
—
|
|
—
|
|
35,466
|
|
—
|
|
35,466
|
|
|||||||
|
Repurchase of common stock
|
(2
|
)
|
(55,500
|
)
|
(21,354
|
)
|
—
|
|
(76,856
|
)
|
—
|
|
(76,856
|
)
|
|||||||
|
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
(24,200
|
)
|
—
|
|
(24,200
|
)
|
—
|
|
(24,200
|
)
|
|||||||
|
Tax
(deficiency)
from employee stock plans
|
—
|
|
(1,369
|
)
|
—
|
|
—
|
|
(1,369
|
)
|
—
|
|
(1,369
|
)
|
|||||||
|
Common stock issued under employee stock plans
|
—
|
|
14,575
|
|
—
|
|
—
|
|
14,575
|
|
—
|
|
14,575
|
|
|||||||
|
Tax withholdings on vesting of restricted stock
|
1
|
|
(10,743
|
)
|
—
|
|
—
|
|
(10,742
|
)
|
—
|
|
(10,742
|
)
|
|||||||
|
Balance at April 1, 2016
|
$
|
101
|
|
$
|
—
|
|
$
|
1,853,602
|
|
$
|
(8,342
|
)
|
$
|
1,845,361
|
|
$
|
8,687
|
|
$
|
1,854,048
|
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
|
Common
Stock
|
Additional
Paid-In
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income/(Loss)
|
Total Dolby
Laboratories,
Inc.
|
Controlling
Interest
|
Total
|
||||||||||||||
|
Balance at September 26, 2014
|
$
|
103
|
|
$
|
46,415
|
|
$
|
1,660,485
|
|
$
|
3,014
|
|
$
|
1,710,017
|
|
$
|
21,631
|
|
$
|
1,731,648
|
|
|
Net income
|
—
|
|
—
|
|
99,331
|
|
—
|
|
99,331
|
|
1,138
|
|
100,469
|
|
|||||||
|
Currency translation adjustments, net of tax of $829
|
—
|
|
—
|
|
—
|
|
(11,211
|
)
|
(11,211
|
)
|
(661
|
)
|
(11,872
|
)
|
|||||||
|
Unrealized gains on investments, net of tax of $(327)
|
—
|
|
—
|
|
—
|
|
665
|
|
665
|
|
—
|
|
665
|
|
|||||||
|
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(5,628
|
)
|
(5,628
|
)
|
|||||||
|
Stock-based compensation expense
|
—
|
|
34,509
|
|
—
|
|
—
|
|
34,509
|
|
—
|
|
34,509
|
|
|||||||
|
Repurchase of common stock
|
(1
|
)
|
(32,363
|
)
|
—
|
|
—
|
|
(32,364
|
)
|
—
|
|
(32,364
|
)
|
|||||||
|
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
(20,470
|
)
|
—
|
|
(20,470
|
)
|
—
|
|
(20,470
|
)
|
|||||||
|
Tax benefit from employee stock plans
|
—
|
|
1,273
|
|
—
|
|
—
|
|
1,273
|
|
—
|
|
1,273
|
|
|||||||
|
Common stock issued under employee stock plans
|
1
|
|
12,630
|
|
—
|
|
—
|
|
12,631
|
|
—
|
|
12,631
|
|
|||||||
|
Tax withholdings on vesting of restricted stock
|
—
|
|
(11,809
|
)
|
—
|
|
—
|
|
(11,809
|
)
|
—
|
|
(11,809
|
)
|
|||||||
|
Exercise of class B stock options
|
—
|
|
7
|
|
—
|
|
—
|
|
7
|
|
—
|
|
7
|
|
|||||||
|
Balance at March 27, 2015
|
$
|
103
|
|
$
|
50,662
|
|
$
|
1,739,346
|
|
$
|
(7,532
|
)
|
$
|
1,782,579
|
|
$
|
16,480
|
|
$
|
1,799,059
|
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
April 1,
2016 |
March 27,
2015 |
||||
|
Operating activities:
|
|
|
||||
|
Net income including controlling interest
|
$
|
98,556
|
|
$
|
100,469
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
||||
|
Depreciation and amortization
|
42,917
|
|
33,578
|
|
||
|
Stock-based compensation
|
35,466
|
|
34,509
|
|
||
|
Amortization of premium on investments
|
2,661
|
|
4,811
|
|
||
|
Excess tax benefit from exercise of stock options
|
(338
|
)
|
(2,095
|
)
|
||
|
Provision for doubtful accounts
|
1,228
|
|
(487
|
)
|
||
|
Deferred income taxes
|
(5,709
|
)
|
(7,681
|
)
|
||
|
Other non-cash items affecting net income
|
498
|
|
1,252
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
||||
|
Accounts receivable
|
(1,727
|
)
|
(3,457
|
)
|
||
|
Inventories
|
(3,533
|
)
|
1,397
|
|
||
|
Prepaid expenses and other assets
|
(6,979
|
)
|
(6,045
|
)
|
||
|
Accounts payable and other liabilities
|
(5,939
|
)
|
3,223
|
|
||
|
Income taxes, net
|
(8,752
|
)
|
12,064
|
|
||
|
Deferred revenue
|
8,495
|
|
5,486
|
|
||
|
Other non-current liabilities
|
22
|
|
916
|
|
||
|
Net cash provided by operating activities
|
156,866
|
|
177,940
|
|
||
|
|
|
|
||||
|
Investing activities:
|
|
|
||||
|
Purchase of investments
|
(200,944
|
)
|
(194,613
|
)
|
||
|
Proceeds from sales of investment securities
|
227,094
|
|
120,074
|
|
||
|
Proceeds from maturities of investment securities
|
59,053
|
|
79,885
|
|
||
|
Purchases of PP&E
|
(48,984
|
)
|
(78,488
|
)
|
||
|
Payments for business acquisitions, net of cash acquired
|
—
|
|
(93,516
|
)
|
||
|
Purchase of intangible assets
|
(105,270
|
)
|
(6,416
|
)
|
||
|
Change in restricted cash
|
(2,342
|
)
|
(14
|
)
|
||
|
Net cash used in investing activities
|
(71,393
|
)
|
(173,088
|
)
|
||
|
|
|
|
||||
|
Financing activities:
|
|
|
||||
|
Proceeds from issuance of common stock
|
14,575
|
|
12,638
|
|
||
|
Repurchase of common stock
|
(76,856
|
)
|
(32,364
|
)
|
||
|
Payment of cash dividend
|
(24,200
|
)
|
(20,470
|
)
|
||
|
Distribution to controlling interest
|
(214
|
)
|
(5,628
|
)
|
||
|
Excess tax benefit from exercise of stock options
|
338
|
|
2,095
|
|
||
|
Shares repurchased for tax withholdings on vesting of restricted stock
|
(10,742
|
)
|
(11,809
|
)
|
||
|
Net cash used in financing activities
|
(97,099
|
)
|
(55,538
|
)
|
||
|
|
|
|
||||
|
Effect of foreign exchange rate changes on cash and cash equivalents
|
902
|
|
(3,792
|
)
|
||
|
Net decrease in cash and cash equivalents
|
(10,724
|
)
|
(54,478
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
531,926
|
|
568,472
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
521,202
|
|
$
|
513,994
|
|
|
|
|
|
||||
|
Supplemental disclosure:
|
|
|
||||
|
Cash paid for income taxes, net of refunds received
|
$
|
39,227
|
|
$
|
26,885
|
|
|
|
|
|
||||
|
Non-cash investing and financing activities:
|
|
|
||||
|
Change in PP&E purchased and unpaid at period-end
|
$
|
(9,592
|
)
|
$
|
27,824
|
|
|
Purchase consideration payable for acquisition
|
$
|
95
|
|
$
|
740
|
|
|
Accounts Receivable, Net
|
April 1,
2016 |
September 25,
2015 |
||||
|
Trade accounts receivable
|
$
|
87,114
|
|
$
|
94,559
|
|
|
Accounts receivable from patent administration program customers
|
17,634
|
|
8,546
|
|
||
|
Accounts receivable, gross
|
104,748
|
|
103,105
|
|
||
|
Less: allowance for doubtful accounts
|
(2,665
|
)
|
(1,542
|
)
|
||
|
Total
|
$
|
102,083
|
|
$
|
101,563
|
|
|
Inventories
|
April 1,
2016 |
September 25,
2015 |
||||
|
Raw materials
|
$
|
4,293
|
|
$
|
3,246
|
|
|
Work in process
|
5,628
|
|
3,279
|
|
||
|
Finished goods
|
7,338
|
|
7,347
|
|
||
|
Total
|
$
|
17,259
|
|
$
|
13,872
|
|
|
Prepaid Expenses And Other Current Assets
|
April 1,
2016 |
September 25,
2015 |
||||
|
Prepaid expenses
|
$
|
17,945
|
|
$
|
13,680
|
|
|
Other current assets
|
7,071
|
|
7,525
|
|
||
|
Income tax receivable
|
11,182
|
|
10,826
|
|
||
|
Total
|
$
|
36,198
|
|
$
|
32,031
|
|
|
Accrued Liabilities
|
April 1,
2016 |
September 25,
2015 |
||||
|
Accrued royalties
|
$
|
2,156
|
|
$
|
1,951
|
|
|
Amounts payable to patent administration program partners
|
55,676
|
|
40,466
|
|
||
|
Accrued compensation and benefits
|
51,229
|
|
70,317
|
|
||
|
Accrued professional fees
|
4,274
|
|
6,523
|
|
||
|
Other accrued liabilities
|
45,199
|
|
50,050
|
|
||
|
Total
|
$
|
158,534
|
|
$
|
169,307
|
|
|
Other Non-Current Liabilities
|
April 1,
2016 |
September 25,
2015 |
||||
|
Supplemental retirement plan obligations
|
$
|
2,418
|
|
$
|
2,400
|
|
|
Non-current tax liabilities
|
56,545
|
|
62,843
|
|
||
|
Other liabilities
|
11,701
|
|
11,781
|
|
||
|
Total
|
$
|
70,664
|
|
$
|
77,024
|
|
|
|
April 1,
2016 |
|||||||||||||||||||||
|
|
Cost
|
Unrealized
|
|
|
Estimated Fair Value
|
|||||||||||||||||
|
|
Gains
|
Losses
|
Total
|
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Cash
|
$
|
494,964
|
|
|
|
$
|
494,964
|
|
|
|
|
|
||||||||||
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Money market funds
|
26,238
|
|
—
|
|
—
|
|
26,238
|
|
|
26,238
|
|
|
|
|||||||||
|
Cash and cash equivalents
|
521,202
|
|
—
|
|
—
|
|
521,202
|
|
|
26,238
|
|
—
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Short-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Commercial paper
|
13,867
|
|
22
|
|
(7
|
)
|
13,882
|
|
|
|
13,882
|
|
|
|||||||||
|
Corporate bonds
|
71,851
|
|
—
|
|
(51
|
)
|
71,800
|
|
|
|
71,800
|
|
|
|||||||||
|
Municipal debt securities
|
18,591
|
|
8
|
|
(14
|
)
|
18,585
|
|
|
|
18,585
|
|
|
|||||||||
|
Short-term investments
|
104,309
|
|
30
|
|
(72
|
)
|
104,267
|
|
|
—
|
|
104,267
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Long-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Certificate of deposit
(1)
|
13,000
|
|
—
|
|
(15
|
)
|
12,985
|
|
|
|
12,985
|
|
|
|||||||||
|
U.S. agency securities
|
11,631
|
|
39
|
|
(1
|
)
|
11,669
|
|
|
11,669
|
|
|
|
|||||||||
|
Government bonds
|
14,483
|
|
70
|
|
(1
|
)
|
14,552
|
|
|
14,552
|
|
|
|
|||||||||
|
Corporate bonds
|
189,585
|
|
810
|
|
(197
|
)
|
190,198
|
|
|
|
190,198
|
|
|
|||||||||
|
Municipal debt securities
|
35,033
|
|
121
|
|
(22
|
)
|
35,132
|
|
|
|
35,132
|
|
|
|||||||||
|
Other long-term investments
(2)
|
3,046
|
|
509
|
|
—
|
|
3,555
|
|
|
509
|
|
|
|
|
||||||||
|
Long-term investments
|
266,778
|
|
1,549
|
|
(236
|
)
|
268,091
|
|
|
26,730
|
|
238,315
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Total cash, cash equivalents, and investments
|
$
|
892,289
|
|
$
|
1,579
|
|
$
|
(308
|
)
|
$
|
893,560
|
|
|
$
|
52,968
|
|
$
|
342,582
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Investments held in supplemental retirement plan:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Assets
|
2,404
|
|
|
|
2,404
|
|
|
2,404
|
|
|
|
|||||||||||
|
Included in prepaid expenses and other current assets & other non-current assets
|
|
|
|
|
|
|||||||||||||||||
|
Liabilities
|
2,404
|
|
|
|
2,404
|
|
|
2,404
|
|
|
|
|||||||||||
|
Included in accrued liabilities & other non-current liabilities
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Contingent consideration related to acquisition:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Liabilities
|
95
|
|
|
|
95
|
|
|
|
|
|
95
|
|
||||||||||
|
Included in accrued liabilities
|
|
|
|
|
|
|||||||||||||||||
|
(1)
|
The certificate of deposit includes marketable securities, and has a maturity in excess of one year as of
April 1, 2016
.
|
|
(2)
|
Other long-term investments as of
April 1, 2016
include a marketable equity security of
$0.5 million
, and other investments that are not carried at fair value including an equity method investment of
$0.6 million
and two cost method investments of
$2.0 million
and
$0.5 million
.
|
|
|
September 25,
2015 |
|||||||||||||||||||||
|
|
Cost
|
Unrealized
|
|
|
Estimated Fair Value
|
|||||||||||||||||
|
|
Gains
|
Losses
|
Total
|
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Cash
|
$
|
511,736
|
|
|
|
$
|
511,736
|
|
|
|
|
|
||||||||||
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Money market funds
|
19,014
|
|
—
|
|
—
|
|
19,014
|
|
|
19,014
|
|
|
|
|||||||||
|
Corporate bonds
|
1,176
|
|
—
|
|
—
|
|
1,176
|
|
|
|
1,176
|
|
|
|||||||||
|
Cash and cash equivalents
|
531,926
|
|
—
|
|
—
|
|
531,926
|
|
|
19,014
|
|
1,176
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Short-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Government bonds
|
2,000
|
|
1
|
|
—
|
|
2,001
|
|
|
2,001
|
|
|
|
|||||||||
|
Commercial paper
|
6,478
|
|
—
|
|
—
|
|
6,478
|
|
|
|
6,478
|
|
|
|||||||||
|
Corporate bonds
|
86,543
|
|
46
|
|
(11
|
)
|
86,578
|
|
|
|
86,578
|
|
|
|||||||||
|
Municipal debt securities
|
43,746
|
|
98
|
|
—
|
|
43,844
|
|
|
|
43,844
|
|
|
|||||||||
|
Short-term investments
|
138,767
|
|
145
|
|
(11
|
)
|
138,901
|
|
|
2,001
|
|
136,900
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Long-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
U.S. agency securities
|
1,999
|
|
1
|
|
—
|
|
2,000
|
|
|
2,000
|
|
|
|
|||||||||
|
Government bonds
|
30,505
|
|
19
|
|
(17
|
)
|
30,507
|
|
|
30,507
|
|
|
|
|||||||||
|
Corporate bonds
|
167,394
|
|
138
|
|
(392
|
)
|
167,140
|
|
|
|
167,140
|
|
|
|||||||||
|
Municipal debt securities
|
117,552
|
|
189
|
|
(60
|
)
|
117,681
|
|
|
|
117,681
|
|
|
|||||||||
|
Other long-term investments
(1)
|
2,961
|
|
726
|
|
—
|
|
3,687
|
|
|
726
|
|
|
|
|||||||||
|
Long-term investments
|
320,411
|
|
1,073
|
|
(469
|
)
|
321,015
|
|
|
33,233
|
|
284,821
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Total cash, cash equivalents, and investments
|
$
|
991,104
|
|
$
|
1,218
|
|
$
|
(480
|
)
|
$
|
991,842
|
|
|
$
|
54,248
|
|
$
|
422,897
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Investments held in supplemental retirement plan:
|
|
|
|
|
|
|
|
|||||||||||||||
|
Assets
|
2,498
|
|
|
|
2,498
|
|
|
2,498
|
|
|
|
|||||||||||
|
Included in prepaid expenses and other current assets & other non-current assets
|
|
|
|
|
|
|||||||||||||||||
|
Liabilities
|
2,498
|
|
|
|
2,498
|
|
|
2,498
|
|
|
|
|||||||||||
|
Included in accrued liabilities & other non-current liabilities
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Contingent consideration related to acquisition:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Liabilities
|
95
|
|
|
|
95
|
|
|
|
|
95
|
|
|||||||||||
|
Included in accrued liabilities
|
|
|
|
|
|
|||||||||||||||||
|
(1)
|
Other long-term investments as of
September 25, 2015
include a marketable equity security of
$0.7 million
, and other investments that are not carried at fair value including an equity method investment of
$0.5 million
and two cost method investments of
$2.0 million
and
$0.5 million
.
|
|
|
April 1, 2016
|
|
September 25, 2015
|
||||||||||
|
Investment Type
|
Fair Value
|
Gross Unrealized Losses
(1)
|
|
Fair Value
|
Gross Unrealized Losses
(1)
|
||||||||
|
Certificate of deposit
|
$
|
12,986
|
|
$
|
(15
|
)
|
|
$
|
—
|
|
$
|
—
|
|
|
U.S. agency securities
|
2,996
|
|
(2
|
)
|
|
19,005
|
|
(17
|
)
|
||||
|
Commercial paper
|
13,860
|
|
(7
|
)
|
|
—
|
|
—
|
|
||||
|
Corporate bonds
|
71,460
|
|
(248
|
)
|
|
148,034
|
|
(403
|
)
|
||||
|
Municipal debt securities
|
18,338
|
|
(36
|
)
|
|
35,476
|
|
(60
|
)
|
||||
|
Total
|
$
|
119,640
|
|
$
|
(308
|
)
|
|
$
|
202,515
|
|
$
|
(480
|
)
|
|
(1)
|
Our available-for-sale securities in an unrealized loss position were in such position for less than twelve months as of both
April 1, 2016
and
September 25, 2015
.
|
|
|
April 1, 2016
|
|
September 25, 2015
|
||||||||||
|
Range of maturity
|
Amortized Cost
|
Fair Value
|
|
Amortized Cost
|
Fair Value
|
||||||||
|
Due within 1 year
|
$
|
130,547
|
|
$
|
130,505
|
|
|
$
|
158,957
|
|
$
|
159,090
|
|
|
Due in 1 to 2 years
|
125,706
|
|
125,932
|
|
|
173,571
|
|
173,577
|
|
||||
|
Due in 2 to 3 years
|
138,027
|
|
138,604
|
|
|
143,879
|
|
143,752
|
|
||||
|
Total
|
$
|
394,280
|
|
$
|
395,041
|
|
|
$
|
476,407
|
|
$
|
476,419
|
|
|
Property, Plant And Equipment
|
April 1,
2016 |
|
September 25,
2015 |
||||
|
Land
|
$
|
43,457
|
|
|
$
|
43,537
|
|
|
Buildings and building improvements
|
261,857
|
|
|
248,390
|
|
||
|
Leasehold improvements
|
60,648
|
|
|
61,455
|
|
||
|
Machinery and equipment
|
74,556
|
|
|
70,143
|
|
||
|
Computer systems and software
|
149,112
|
|
|
136,666
|
|
||
|
Furniture and fixtures
|
27,197
|
|
|
25,489
|
|
||
|
Equipment provided under operating leases
|
22,318
|
|
|
7,638
|
|
||
|
Construction-in-progress
|
4,673
|
|
|
11,448
|
|
||
|
Property, plant and equipment, gross
|
643,818
|
|
|
604,766
|
|
||
|
Less: accumulated depreciation
|
(227,564
|
)
|
|
(201,675
|
)
|
||
|
Property, plant and equipment, net
|
$
|
416,254
|
|
|
$
|
403,091
|
|
|
|
Goodwill
|
||
|
Balance at September 25, 2015
|
$
|
307,708
|
|
|
Translation adjustments
|
2,172
|
|
|
|
Balance at April 1, 2016
|
$
|
309,880
|
|
|
|
April 1, 2016
|
|
September 25, 2015
|
||||||||||||||||
|
Intangible Assets, Net
|
Cost
|
Accumulated
Amortization
|
Net
|
|
Cost
|
Accumulated
Amortization
|
Net
|
||||||||||||
|
Acquired patents and technology
|
$
|
278,222
|
|
$
|
(88,261
|
)
|
$
|
189,961
|
|
|
$
|
172,787
|
|
$
|
(74,398
|
)
|
$
|
98,389
|
|
|
Customer relationships
|
56,826
|
|
(31,262
|
)
|
25,564
|
|
|
56,933
|
|
(28,275
|
)
|
28,658
|
|
||||||
|
Other intangibles
|
22,722
|
|
(22,165
|
)
|
557
|
|
|
22,564
|
|
(22,104
|
)
|
460
|
|
||||||
|
Total
|
$
|
357,770
|
|
$
|
(141,688
|
)
|
$
|
216,082
|
|
|
$
|
252,284
|
|
$
|
(124,777
|
)
|
$
|
127,507
|
|
|
Fiscal Period
|
Total Purchase Consideration
|
Weighted-Average Useful Life
|
Income Statement Classification: Amortization Expense
|
|
|
(in millions)
|
(in years)
|
|
|
Fiscal 2015
|
|
|
|
|
Q1 - Quarter ended December 26, 2014
|
$6.4
|
18.0
|
Cost of Revenue
|
|
Q2 - Quarter ended March 27, 2015
|
—
|
0
|
|
|
|
$6.4
|
18.0
|
|
|
|
|
|
|
|
Fiscal 2016
|
|
|
|
|
Q1 - Quarter ended January 1, 2016
|
$105.3
|
9.0
|
Cost of Revenue
|
|
Q2 - Quarter ended April 1, 2016
|
—
|
0
|
|
|
|
$105.3
|
9.0
|
|
|
Fiscal Year
|
Amortization Expense
|
||
|
Remainder of 2016
|
$
|
16,140
|
|
|
2017
|
29,660
|
|
|
|
2018
|
24,214
|
|
|
|
2019
|
23,630
|
|
|
|
2020
|
23,405
|
|
|
|
Thereafter
|
99,033
|
|
|
|
Total
|
$
|
216,082
|
|
|
|
Shares
|
Weighted-Average
Exercise Price
|
Weighted-Average
Remaining
Contractual Life
|
Aggregate
Intrinsic
Value
(1)
|
|||||
|
|
(in thousands)
|
|
(in years)
|
(in thousands)
|
|||||
|
Options outstanding at September 25, 2015
|
8,835
|
|
$
|
35.85
|
|
|
|
||
|
Grants
|
2,187
|
|
33.21
|
|
|
|
|||
|
Exercises
|
(345
|
)
|
29.18
|
|
|
|
|||
|
Forfeitures and cancellations
|
(230
|
)
|
40.32
|
|
|
|
|||
|
Options outstanding at April
1, 2016
|
10,447
|
|
35.41
|
|
7.3
|
$
|
83,774
|
|
|
|
Options vested and expected to vest at April
1, 2016
|
9,718
|
|
35.35
|
|
7.2
|
78,586
|
|
||
|
Options exercisable at April
1, 2016
|
5,451
|
|
$
|
33.90
|
|
6.0
|
51,366
|
|
|
|
(1)
|
Aggregate intrinsic value is based on the closing price of our common stock on
April 1, 2016
of
$43.37
and excludes the impact of options that were not in-the-money.
|
|
|
Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||
|
|
(in thousands)
|
|
|||
|
Non-vested at September 25, 2015
|
2,830
|
|
$
|
40.73
|
|
|
Granted
|
1,260
|
|
33.57
|
|
|
|
Vested
|
(953
|
)
|
36.45
|
|
|
|
Forfeitures
|
(113
|
)
|
38.76
|
|
|
|
Non-vested at
April
1, 2016
|
3,024
|
|
$
|
39.17
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
||||
|
Expected term (in years)
|
5.24
|
|
5.21
|
|
|
5.24
|
|
4.60
|
|
|
Risk-free interest rate
|
1.5
|
%
|
1.6
|
%
|
|
1.7
|
%
|
1.5
|
%
|
|
Expected stock price volatility
|
30.1
|
%
|
29.5
|
%
|
|
29.8
|
%
|
29.7
|
%
|
|
Dividend yield
|
1.4
|
%
|
1.0
|
%
|
|
1.4
|
%
|
0.9
|
%
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
||||||||
|
Compensation Expense - By Type
|
|
|
|
|
|
||||||||
|
Stock options
|
$
|
4,998
|
|
$
|
5,729
|
|
|
$
|
11,364
|
|
$
|
12,012
|
|
|
Restricted stock units
|
10,267
|
|
10,077
|
|
|
22,343
|
|
20,292
|
|
||||
|
Employee stock purchase plan
|
821
|
|
861
|
|
|
1,759
|
|
2,205
|
|
||||
|
Total stock-based compensation
|
16,086
|
|
16,667
|
|
|
35,466
|
|
34,509
|
|
||||
|
Benefit from income taxes
|
(4,706
|
)
|
(4,890
|
)
|
|
(10,412
|
)
|
(10,041
|
)
|
||||
|
Total stock-based compensation, net of tax
|
$
|
11,380
|
|
$
|
11,777
|
|
|
$
|
25,054
|
|
$
|
24,468
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
||||||||
|
Compensation Expense - By Classification
|
|
|
|
|
|||||||||
|
Cost of products
|
$
|
219
|
|
$
|
224
|
|
|
$
|
499
|
|
$
|
470
|
|
|
Cost of services
|
114
|
|
115
|
|
|
243
|
|
237
|
|
||||
|
Research and development
|
4,268
|
|
4,938
|
|
|
9,375
|
|
10,212
|
|
||||
|
Sales and marketing
|
6,441
|
|
5,576
|
|
|
14,151
|
|
11,485
|
|
||||
|
General and administrative
|
5,044
|
|
5,814
|
|
|
11,198
|
|
12,105
|
|
||||
|
Total stock-based compensation
|
16,086
|
|
16,667
|
|
|
35,466
|
|
34,509
|
|
||||
|
Benefit from income taxes
|
(4,706
|
)
|
(4,890
|
)
|
|
(10,412
|
)
|
(10,041
|
)
|
||||
|
Total stock-based compensation, net of tax
|
$
|
11,380
|
|
$
|
11,777
|
|
|
$
|
25,054
|
|
$
|
24,468
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
||||||||
|
Tax benefit - stock option exercises & shares issued under ESPP
|
$
|
28
|
|
$
|
19
|
|
|
$
|
123
|
|
$
|
187
|
|
|
Authorization Period
|
Authorization Amount
|
||
|
Fiscal 2010: November 2009
|
$
|
250,000
|
|
|
Fiscal 2010: July 2010
|
300,000
|
|
|
|
Fiscal 2011: July 2011
|
250,000
|
|
|
|
Fiscal 2012: February 2012
|
100,000
|
|
|
|
Fiscal 2015: October 2014
|
200,000
|
|
|
|
Total
|
$
|
1,100,000
|
|
|
Quarterly Repurchase Activity
|
Shares
Repurchased
|
Cost
(1)
|
Average Price Paid Per Share
(2)
|
|||||
|
|
|
(in thousands)
|
|
|||||
|
Q1 - Quarter ended January 1, 2016
|
1,140,700
|
|
$
|
39,449
|
|
$
|
34.57
|
|
|
Q2 - Quarter ended April 1, 2016
|
975,745
|
|
37,407
|
|
38.32
|
|
||
|
Total
|
2,116,445
|
|
$
|
76,856
|
|
|
||
|
(1)
|
Cost of share repurchases includes the price paid per share and applicable commissions.
|
|
(2)
|
Average price paid per share excludes commission costs.
|
|
Fiscal Period
|
Declaration Date
|
Record Date
|
Payment Date
|
Cash Dividend Per Common Share
|
Dividend Payment
|
|
||
|
Fiscal 2016
|
|
|
|
|
|
|
||
|
Q1 - Quarter ended January 1, 2016
|
January 25, 2016
|
February 8, 2016
|
February 17, 2016
|
$
|
0.12
|
|
$12.1 million
|
|
|
Q2 - Quarter ended April 1, 2016
|
April 25, 2016
|
May 9, 2016
|
May 18, 2016
|
$
|
0.12
|
|
$12.0 million
|
(1)
|
|
(1)
|
The amount of the dividend payment is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.
|
|
|
Fiscal Quarter Ended
April 1, 2016
|
|
Fiscal Year-To-Date Ended
April 1, 2016
|
||||||||||||||||
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
||||||||||||
|
Balance, beginning of period
|
$
|
(510
|
)
|
$
|
(12,413
|
)
|
$
|
(12,923
|
)
|
|
$
|
350
|
|
$
|
(11,812
|
)
|
$
|
(11,462
|
)
|
|
Other comprehensive income/(loss) before reclassifications:
|
|
|
|
|
|
|
|
||||||||||||
|
Unrealized gains - investment securities
|
1,401
|
|
|
|
1,401
|
|
|
242
|
|
|
|
242
|
|
||||||
|
Foreign currency translation gains
(1)
|
|
|
3,173
|
|
3,173
|
|
|
|
|
2,229
|
|
2,229
|
|
||||||
|
Income tax effect - benefit/(expense)
|
(94
|
)
|
(155
|
)
|
(249
|
)
|
|
105
|
|
188
|
|
293
|
|
||||||
|
Net of tax
|
1,307
|
|
3,018
|
|
4,325
|
|
|
347
|
|
2,417
|
|
2,764
|
|
||||||
|
Amounts reclassified from AOCI into earnings:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Realized gains - investment securities
(1)
|
347
|
|
|
|
347
|
|
|
478
|
|
|
|
478
|
|
||||||
|
Income tax effect - (expense)
(2)
|
(91
|
)
|
|
|
(91
|
)
|
|
(122
|
)
|
|
|
(122
|
)
|
||||||
|
Net of tax
|
256
|
|
—
|
|
256
|
|
|
356
|
|
—
|
|
356
|
|
||||||
|
Net current-period other comprehensive income
|
1,563
|
|
3,018
|
|
4,581
|
|
|
703
|
|
2,417
|
|
3,120
|
|
||||||
|
Balance, end of period
|
$
|
1,053
|
|
$
|
(9,395
|
)
|
$
|
(8,342
|
)
|
|
$
|
1,053
|
|
$
|
(9,395
|
)
|
$
|
(8,342
|
)
|
|
|
Fiscal Quarter Ended
March 27, 2015
|
|
Fiscal Year-To-Date Ended
March 27, 2015
|
||||||||||||||||
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
||||||||||||
|
Balance, beginning of period
|
$
|
328
|
|
$
|
(2,516
|
)
|
$
|
(2,188
|
)
|
|
$
|
505
|
|
$
|
2,509
|
|
$
|
3,014
|
|
|
Other comprehensive income/(loss) before reclassifications:
|
|
|
|
|
|
|
|
||||||||||||
|
Unrealized gains - investment securities
|
1,554
|
|
|
1,554
|
|
|
1,169
|
|
|
1,169
|
|
||||||||
|
Foreign currency translation (losses)
(1)
|
|
(6,487
|
)
|
(6,487
|
)
|
|
|
(12,040
|
)
|
(12,040
|
)
|
||||||||
|
Income tax effect - benefit/(expense)
|
(507
|
)
|
301
|
|
(206
|
)
|
|
(327
|
)
|
829
|
|
502
|
|
||||||
|
Net of tax
|
1,047
|
|
(6,186
|
)
|
(5,139
|
)
|
|
842
|
|
(11,211
|
)
|
(10,369
|
)
|
||||||
|
Amounts reclassified from AOCI into earnings:
|
|
|
|
|
|
|
|
||||||||||||
|
Realized (losses) - investment securities
(1)
|
(218
|
)
|
|
(218
|
)
|
|
(204
|
)
|
|
(204
|
)
|
||||||||
|
Income tax effect - benefit
(2)
|
13
|
|
|
13
|
|
|
27
|
|
|
27
|
|
||||||||
|
Net of tax
|
(205
|
)
|
—
|
|
(205
|
)
|
|
(177
|
)
|
—
|
|
(177
|
)
|
||||||
|
Net current-period other comprehensive income/(loss)
|
842
|
|
(6,186
|
)
|
(5,344
|
)
|
|
665
|
|
(11,211
|
)
|
(10,546
|
)
|
||||||
|
Balance, end of period
|
$
|
1,170
|
|
$
|
(8,702
|
)
|
$
|
(7,532
|
)
|
|
$
|
1,170
|
|
$
|
(8,702
|
)
|
$
|
(7,532
|
)
|
|
(1)
|
Realized gains or losses from the sale of our available-for-sale investment securities or from foreign currency translation adjustments are included within other income/expense, net in our consolidated statements of operations.
|
|
(2)
|
The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations.
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
||||||||
|
Numerator:
|
|
|
|
|
|
||||||||
|
Net income attributable to Dolby Laboratories, Inc.
|
$
|
67,398
|
|
$
|
57,974
|
|
|
$
|
98,299
|
|
$
|
99,331
|
|
|
|
|
|
|
|
|
||||||||
|
Denominator:
|
|
|
|
|
|
||||||||
|
Weighted-average shares outstanding—basic
|
100,456
|
|
102,509
|
|
|
100,600
|
|
102,406
|
|
||||
|
Potential common shares from options to purchase common stock
|
748
|
|
889
|
|
|
674
|
|
941
|
|
||||
|
Potential common shares from restricted stock units
|
351
|
|
506
|
|
|
442
|
|
750
|
|
||||
|
Weighted-average shares outstanding—diluted
|
101,555
|
|
103,904
|
|
|
101,716
|
|
104,097
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Net income per share attributable to Dolby Laboratories, Inc.:
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.67
|
|
$
|
0.57
|
|
|
$
|
0.98
|
|
$
|
0.97
|
|
|
Diluted
|
$
|
0.66
|
|
$
|
0.56
|
|
|
$
|
0.97
|
|
$
|
0.95
|
|
|
|
|
|
|
|
|
||||||||
|
Antidilutive awards excluded from calculation:
|
|
|
|
|
|
||||||||
|
Stock options
|
7,124
|
|
4,604
|
|
|
6,349
|
|
3,684
|
|
||||
|
Restricted stock units
|
733
|
|
934
|
|
|
184
|
|
106
|
|
||||
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
||||||||
|
Withholding taxes
|
$
|
12,406
|
|
$
|
11,942
|
|
|
$
|
22,188
|
|
$
|
24,142
|
|
|
|
Payments Due By Fiscal Period
|
||||||||||||||||||||
|
|
Remainder Of
Fiscal 2016 |
Fiscal
2017 |
Fiscal
2018 |
Fiscal
2019 |
Fiscal
2020 |
Thereafter
|
Total
|
||||||||||||||
|
Naming rights
|
$
|
—
|
|
$
|
7,619
|
|
$
|
7,715
|
|
$
|
7,811
|
|
$
|
7,909
|
|
$
|
102,980
|
|
$
|
134,034
|
|
|
Donation commitments
|
3,155
|
|
6,300
|
|
322
|
|
322
|
|
322
|
|
1,013
|
|
11,434
|
|
|||||||
|
Operating leases
|
6,823
|
|
12,340
|
|
10,308
|
|
8,091
|
|
7,565
|
|
30,700
|
|
75,827
|
|
|||||||
|
Purchase obligations
|
13,566
|
|
13,103
|
|
1,199
|
|
—
|
|
—
|
|
—
|
|
27,868
|
|
|||||||
|
Total
|
$
|
23,544
|
|
$
|
39,362
|
|
$
|
19,544
|
|
$
|
16,224
|
|
$
|
15,796
|
|
$
|
134,693
|
|
$
|
249,163
|
|
|
Purchase Price Allocation
|
|
||
|
Current assets
|
$
|
17,231
|
|
|
Inventories
|
16,372
|
|
|
|
Intangible assets
|
45,600
|
|
|
|
Goodwill
|
39,672
|
|
|
|
Current liabilities
|
(11,653
|
)
|
|
|
Non-current liabilities
|
(8,820
|
)
|
|
|
Cash consideration paid to sellers
|
98,402
|
|
|
|
Add: contingent consideration
|
740
|
|
|
|
Total purchase consideration
|
$
|
99,142
|
|
|
Intangible Assets Acquired
|
Purchase Price Allocation
|
Weighted-Average Useful Life (Years)
|
Income Statement Classification: Amortization Expense
|
|
Customer relationships
|
$25,600
|
10
|
Sales & Marketing
|
|
Developed technology
|
17,500
|
7.5
|
Cost of Sales
|
|
Trade name
|
1,300
|
1
|
Sales & Marketing
|
|
Backlog
|
1,200
|
1
|
Cost of Sales
|
|
Total
|
$45,600
|
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||
|
Revenue
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
|
Licensing
|
91%
|
90%
|
|
89%
|
91%
|
|
Products
|
7%
|
8%
|
|
9%
|
7%
|
|
Services
|
2%
|
2%
|
|
2%
|
2%
|
|
Total
|
100%
|
100%
|
|
100%
|
100%
|
|
|
Fiscal Year-To-Date Ended
|
|
|
Revenue By Geographic Location
|
April 1,
2016 |
March 27,
2015 |
|
United States
|
29%
|
28%
|
|
International
|
71%
|
72%
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
|
||
|
Market
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
Main Offerings Incorporating Our Technologies
|
|
Broadcast
|
45%
|
42%
|
|
46%
|
41%
|
Televisions & STBs
|
|
PC
|
16%
|
17%
|
|
16%
|
17%
|
Windows operating systems & DVD software players
|
|
Consumer Electronics
|
14%
|
15%
|
|
14%
|
15%
|
DVD and Blu-ray Disc devices, AVRs, DMAs, HTIBs & Soundbars
|
|
Mobile
|
11%
|
11%
|
|
10%
|
13%
|
Smartphones, tablets & other mobile devices
|
|
Other
|
14%
|
15%
|
|
14%
|
14%
|
Gaming consoles, auto DVD, audio conferencing & Dolby Cinema
|
|
Total
|
100%
|
100%
|
|
100%
|
100%
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||
|
Market
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
|
Cinema
|
98%
|
92%
|
|
98%
|
91%
|
|
Broadcast & Other
|
2%
|
8%
|
|
2%
|
9%
|
|
Total
|
100%
|
100%
|
|
100%
|
100%
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
Licensing
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
Revenue
|
$249,336
|
$243,333
|
$6,003
|
2%
|
|
$460,465
|
$459,931
|
$534
|
—%
|
|
Percentage of total revenue
|
91%
|
90%
|
|
|
|
89%
|
91%
|
|
|
|
Cost of licensing
|
6,698
|
3,787
|
2,911
|
77%
|
|
13,231
|
7,268
|
5,963
|
82%
|
|
Gross margin
|
242,638
|
239,546
|
3,092
|
1%
|
|
447,234
|
452,663
|
(5,429)
|
(1)%
|
|
Gross margin percentage
|
97%
|
98%
|
|
|
|
97%
|
98%
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Broadcast
|
á
|
Increase in recoveries along with higher volumes
|
â
|
Increase in cost of licensing primarily due to amortization on newly-acquired intangible assets
|
|
CE
|
â
|
Lower recoveries and lower units of AVRs, Blu-ray and HTiBs that incorporate our technologies, partially offset by higher units of DMAs and revenue from Via Licensing patent pools
|
||
|
Other
|
â
|
Lower recoveries from gaming consoles, partially offset by higher revenues from Automotive and Dolby Cinema
|
||
|
Mobile
|
â
|
Decrease primarily due to timing of revenue under contractual arrangements, partially offset by revenue streams from newer licensing activity
|
||
|
PC
|
á
|
Higher recoveries, partially offset by declines in PC market volumes
|
||
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Broadcast
|
á
|
Increase in recoveries and higher volumes
|
â
|
Increase in cost of licensing primarily due to amortization on newly-acquired intangible assets
|
|
Mobile
|
â
|
Decrease primarily due to timing of revenue under contractual arrangements, partially offset by revenue streams from newer licensing activity
|
||
|
CE
|
â
|
Lower recoveries, lower units of DVDs, HTIBs and Blu-ray players that incorporate our technologies, partially offset by higher units of DMAs and revenue from Via Licensing patent pools
|
||
|
PC
|
â
|
Lower units largely attributed to declines in PC market volumes, partially offset by higher recoveries
|
||
|
Other
|
ßà
|
No significant fluctuations
|
||
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
Products
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
Revenue
|
$20,063
|
$22,985
|
$(2,922)
|
(13)%
|
|
$44,872
|
$36,248
|
$8,624
|
24%
|
|
Percentage of total revenue
|
7%
|
8%
|
|
|
|
9%
|
7%
|
|
|
|
Cost of products
|
13,978
|
18,237
|
(4,259)
|
(23)%
|
|
33,016
|
30,821
|
2,195
|
7%
|
|
Gross margin
|
6,085
|
4,748
|
1,337
|
28%
|
|
11,856
|
5,427
|
6,429
|
118%
|
|
Gross margin percentage
|
30%
|
21%
|
|
|
|
26%
|
15%
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Cinema
|
â
|
Lower units and ASPs for both digital cinema video and audio products, partially offset by higher units of 3D glasses and Atmos products
|
á
|
Improved results on extended warranty programs combined with lower manufacturing variances, partially offset by a less favorable product mix
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Cinema
|
á
|
Increased warranty revenues, higher volume from 3D, Atmos, and digital cinema audio and video products
|
á
|
More favorable product mix and lower charges from excess and obsolete inventory
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
Services
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
Revenue
|
$4,941
|
$5,632
|
$(691)
|
(12)%
|
|
$9,817
|
$10,009
|
$(192)
|
(2)%
|
|
Percentage of total revenue
|
2%
|
2%
|
|
|
|
2%
|
2%
|
|
|
|
Cost of services
|
3,697
|
3,125
|
572
|
18%
|
|
7,892
|
6,470
|
1,422
|
22%
|
|
Gross margin
|
1,244
|
2,507
|
(1,263)
|
(50)%
|
|
1,925
|
3,539
|
(1,614)
|
(46)%
|
|
Gross margin percentage
|
25%
|
45%
|
|
|
|
20%
|
35%
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Configuration & Post-Production
|
â
|
Lower film mastering and other services
|
â
|
Lower production service revenue combined with high proportion of fixed costs
|
|
Support & Other
|
ßà
|
No significant fluctuations
|
â
|
Higher labor and maintenance-related costs
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Configuration & Post-Production
|
â
|
Lower film mastering and other services
|
â
|
Lower production service revenue combined with high proportion of fixed costs
|
|
Support & Other
|
á
|
Higher support and maintenance revenue
|
â
|
Higher support and maintenance-related costs
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
Research and development
|
$52,088
|
$56,601
|
$(4,513)
|
(8)%
|
|
$105,416
|
$105,195
|
$221
|
—%
|
|
Percentage of total revenue
|
19%
|
21%
|
|
|
|
20%
|
21%
|
|
|
|
Category
|
Key Drivers
|
|
|
Product Development
|
â
|
Lower prototype costs
|
|
Technology & Communications
|
â
|
Lower expenses associated with software licensing arrangements
|
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the employee base aimed at existing or new research and development projects
|
|
Facilities
|
á
|
Higher costs associated with our new worldwide headquarters and additional laboratories
|
|
Category
|
Key Drivers
|
|
|
Product Development
|
â
|
Lower prototype costs
|
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the employee base aimed at existing or new research and development projects
|
|
Facilities
|
á
|
Higher costs associated with our new worldwide headquarters and additional laboratories
|
|
Technology & Communications
|
â
|
Lower expenses associated with software licensing arrangements
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
Sales and marketing
|
$71,815
|
$65,940
|
$5,875
|
9%
|
|
$146,269
|
$133,958
|
$12,311
|
9%
|
|
Percentage of total revenue
|
26%
|
24%
|
|
|
|
28%
|
26%
|
|
|
|
Category
|
Key Drivers
|
|
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the existing employee base, partially offset by lower variable compensation costs
|
|
Facilities
|
á
|
Higher costs associated with our new worldwide headquarters and additional laboratories
|
|
Stock-Based Compensation
|
á
|
Higher headcount relative to the prior fiscal comparative period
|
|
Category
|
Key Drivers
|
|
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the existing employee base, partially offset by lower variable compensation costs
|
|
Facilities
|
á
|
Higher costs associated with our new worldwide headquarters and additional laboratories
|
|
Stock-Based Compensation
|
á
|
Higher headcount and an increase in award grants relative to the prior fiscal comparative period
|
|
Marketing Programs
|
á
|
Higher costs associated with the recent launch of Dolby Cinema and marketing activities supporting other growth initiatives
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
General and administrative
|
$42,482
|
$45,653
|
$(3,171)
|
(7)%
|
|
$86,560
|
$90,369
|
$(3,809)
|
(4)%
|
|
Percentage of total revenue
|
15%
|
17%
|
|
|
|
17%
|
18%
|
|
|
|
Category
|
Key Drivers
|
|
|
Facilities
|
â
|
Lower proportionate costs associated with our new worldwide headquarters and additional laboratories
|
|
Legal, Professional & Consulting Fees
|
á
|
Higher costs associated with other legal activities
|
|
Compensation & Benefits
|
â
|
Lower variable compensation costs
|
|
Category
|
Key Drivers
|
|
|
Facilities
|
â
|
Lower proportionate costs associated with our new worldwide headquarters and additional laboratories
|
|
Legal, Professional & Consulting Fees
|
â
|
Higher costs associated with patent filings and other legal activities
|
|
Depreciation & Amortization
|
á
|
Higher depreciation from assets placed into service
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
Other Income/Expense
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
April 1,
2016 |
March 27,
2015 |
$
|
%
|
|
Interest income
|
$1,250
|
$1,091
|
$159
|
15%
|
|
$2,547
|
$1,991
|
$556
|
28%
|
|
Interest expense
|
(33)
|
(31)
|
(2)
|
6%
|
|
(62)
|
(46)
|
(16)
|
35%
|
|
Other income/(expense), net
|
279
|
218
|
61
|
28%
|
|
(693)
|
110
|
(803)
|
(730)%
|
|
Total
|
$1,496
|
$1,278
|
$218
|
17%
|
|
$1,792
|
$2,055
|
$(263)
|
(13)%
|
|
Category
|
Key Drivers
|
|
|
Interest Income
|
á
|
Increase due to higher yields on our investment balances relative to the prior fiscal comparative period
|
|
Category
|
Key Drivers
|
|
|
Other Income/(Expense)
|
â
|
Increase in other expense primarily from higher currency translation losses caused by unfavorable fluctuations in foreign exchange rates
|
|
Interest Income
|
á
|
Increase due to higher yields on our investment balances relative to the prior fiscal comparative period
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||
|
|
April 1,
2016 |
March 27,
2015 |
|
April 1,
2016 |
March 27,
2015 |
|
Provision for income taxes
|
$(16,278)
|
$(21,353)
|
|
$(24,751)
|
$(33,732)
|
|
Effective tax rate
|
19%
|
27%
|
|
20%
|
25%
|
|
Factor
|
Impact On Effective Tax Rate
|
|
|
Tax Contingencies
|
â
|
Increased benefit from the settlement of a California state audit for the tax years 2005 to 2007
|
|
Federal R&D Credits
|
â
|
Increased benefit from federal R&D credits
|
|
Factor
|
Impact On Effective Tax Rate
|
|
|
Tax Contingencies
|
â
|
Increased benefit due to the impact of the settlement of the California audit for the tax years 2005 to 2007
|
|
Federal R&D Credits
|
â
|
Increased benefit from federal R&D credits
|
|
|
April 1,
2016 |
September 25,
2015 |
||||
|
|
(in thousands)
|
|||||
|
Cash and cash equivalents
|
$
|
521,202
|
|
$
|
531,926
|
|
|
Short-term investments
|
104,267
|
|
138,901
|
|
||
|
Long-term investments
|
268,091
|
|
321,015
|
|
||
|
Accounts receivable, net
|
102,083
|
|
101,563
|
|
||
|
Accounts payable and accrued liabilities
|
176,166
|
|
190,017
|
|
||
|
Working capital
(1)
|
587,800
|
|
611,548
|
|
||
|
(1)
|
Working capital consists of total current assets less total current liabilities.
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
April 1,
2016 |
March 27,
2015 |
||||
|
Net cash provided by operating activities
|
$
|
156,866
|
|
$
|
177,940
|
|
|
Factor
|
Impact On Cash Flows
|
|
|
Working Capital
|
â
|
Net overall decrease attributed to high fluctuations in income tax liabilities
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
April 1,
2016 |
March 27,
2015 |
||||
|
Net cash used in investing activities
|
$
|
(71,393
|
)
|
$
|
(173,088
|
)
|
|
Capital expenditures
|
(48,984
|
)
|
(78,488
|
)
|
||
|
Factor
|
Impact On Cash Flows
|
|
|
Acquisition Of Intangible Assets
|
â
|
Significant outflows in fiscal 2016 for the purchase of a patent portfolio (refer to Note 6 for additional information)
|
|
Business Combinations
|
á
|
Lower outflows as the prior comparable period included our acquisition of Doremi in fiscal 2015
|
|
Proceeds From Investments
|
á
|
Higher inflows from the sale & maturity of marketable investment securities during the current fiscal period
|
|
Capital Expenditures
|
á
|
Lower expenditures for PP&E
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
April 1,
2016 |
March 27,
2015 |
||||
|
Net cash used in financing activities
|
$
|
(97,099
|
)
|
$
|
(55,538
|
)
|
|
Repurchase of common stock
|
(76,856
|
)
|
(32,364
|
)
|
||
|
Factor
|
Impact On Cash Flows
|
|
|
Share Repurchases
|
â
|
Increased outflows resulting from a higher volume of common stock repurchases
|
|
Partnership Distribution
|
á
|
Lower distributions to our controlling interest for accumulated commercial property leasing fees in the current fiscal year-to-date period
|
|
Dividend Payments
|
â
|
Higher outflows for the payment of our quarterly cash dividend to common stockholders primarily as a result of a $0.02 per share increase compared to the prior fiscal year
|
|
•
|
Australian Dollar
|
|
•
|
British Pound
|
|
•
|
Chinese Yuan
|
|
•
|
Euro
|
|
•
|
Indian Rupee
|
|
•
|
Japanese Yen
|
|
•
|
Korean Won
|
|
•
|
Polish Zloty
|
|
•
|
Russian Ruble
|
|
•
|
Swedish Krona
|
|
•
|
Purchasing trends away from traditional PCs and toward computing devices without optical disc drives, such as ultrabooks and tablets;
|
|
•
|
Because PC OEMs are required to pay us a higher per-unit royalty for Windows 8 and Windows 10 PCs that include optical disc playback functionality than Windows 8 or Windows 10 PCs that do not include such functionality, the continued decreasing inclusion of optical disc drives in Windows 8 or Windows 10 PCs will result in lower per-unit royalties;
|
|
•
|
PC software that includes our technologies on an unauthorized and infringing basis, for which we receive no royalty payments; and
|
|
•
|
Continued decreasing inclusion of independent software vendor media applications by PC OEMs.
|
|
•
|
Exhibitors may choose competing products with different features or lower prices; and
|
|
•
|
Pricing and other competitive pressures have caused us to implement pricing strategies which have adversely affected gross margins of our cinema products.
|
|
•
|
Timing of royalty reports from our licensees and meeting revenue recognition criteria;
|
|
•
|
Royalty reports including positive or negative corrective adjustments;
|
|
•
|
Retroactive royalties that cover extended periods of time; and
|
|
•
|
Timing of revenue recognition under licensing agreements and other contractual arrangements, including recognition of unusually large amounts of revenue in any given quarter because not all of our revenue recognition criteria were met in prior periods.
|
|
•
|
Rapid technological change;
|
|
•
|
New and improved technology and frequent product introductions;
|
|
•
|
Changing consumer and licensee demands;
|
|
•
|
Evolving industry standards; and
|
|
•
|
Technology and product obsolescence.
|
|
•
|
Possibility that innovations may not be protectable;
|
|
•
|
Failure to protect innovations that later turn out to be important;
|
|
•
|
Insufficient patent protection to prevent third parties from designing around our patent claims;
|
|
•
|
Our pending patent applications may not be approved; and
|
|
•
|
Possibility that an issued patent may later be found to be invalid or unenforceable.
|
|
•
|
Our ability to enforce our contractual and intellectual property rights, especially in countries that do not recognize and enforce intellectual property rights to the same extent as the U.S., Japan, Korea, and European countries do, which increases the risk of unauthorized use of our technologies;
|
|
•
|
Limited or no patent protection for our Dolby Digital technologies in countries such as China, Taiwan, and India, which may require us to obtain patent rights for new and existing technologies in order to grow or maintain our revenue; and
|
|
•
|
Because of limitations in the legal systems in many countries, our ability to obtain and enforce patents in many countries is uncertain, and we must strengthen and develop relationships with entertainment industry participants worldwide to increase our ability to enforce our intellectual property and contractual rights without relying solely on the legal systems in the countries in which we operate.
|
|
•
|
Content creators, such as film directors, studios, music producers and mobile and online content producers;
|
|
•
|
Content distributors, such as film exhibitors, broadcasters, operators, and OTT video service providers and video game publishers; and
|
|
•
|
Device manufacturers.
|
|
•
|
Diversion of management time and focus from operating our business to acquisition integration challenges;
|
|
•
|
Cultural and logistical challenges associated with integrating employees from acquired businesses into our organization;
|
|
•
|
Retaining employees, suppliers and customers from businesses we acquire;
|
|
•
|
The need to implement or improve internal controls, procedures, and policies appropriate for a public company at businesses that prior to the acquisition may have lacked effective controls, procedures, and policies;
|
|
•
|
Possible write-offs or impairment charges resulting from acquisitions;
|
|
•
|
Unanticipated or unknown liabilities relating to acquired businesses; and
|
|
•
|
The need to integrate acquired businesses’ accounting, management information, manufacturing, human resources, and other administrative systems to permit effective management.
|
|
•
|
U.S. and foreign government trade restrictions, including those which may impose restrictions on importation of programming, technology, or components to or from the U.S.;
|
|
•
|
Compliance with applicable international laws and regulations, including antitrust laws, that may differ or conflict with laws in other countries where we conduct business, or are otherwise not harmonized with one another;
|
|
•
|
Foreign government taxes, regulations, and permit requirements, including foreign taxes that we may not be able to offset against taxes imposed upon us in the U.S., and other laws limiting our ability to repatriate funds to the U.S.;
|
|
•
|
Changes in diplomatic and trade relationships;
|
|
•
|
Difficulty in establishing, staffing, and managing foreign operations;
|
|
•
|
Adverse fluctuations in foreign currency exchange rates and interest rates, including risks related to any interest rate swap or other hedging activities we undertake;
|
|
•
|
Political or social instability, natural disasters, war or events of terrorism; and
|
|
•
|
The strength of international economies.
|
|
•
|
Earnings being lower than anticipated in countries that have lower tax rates and higher than anticipated in countries that have higher tax rates;
|
|
•
|
Changes in the valuation of our deferred tax assets and liabilities;
|
|
•
|
Fluctuations in tax exempt interest income;
|
|
•
|
Transfer pricing adjustments;
|
|
•
|
Tax effects of nondeductible compensation;
|
|
•
|
Tax costs related to intercompany realignments;
|
|
•
|
Any obligations or decisions to repatriate earnings from abroad earlier than anticipated;
|
|
•
|
Changes in accounting principles; or
|
|
•
|
Changes in tax laws and regulations in the countries in which we operate, including U.S. legislative changes to the taxation of earnings of our foreign subsidiaries.
|
|
Repurchase Activity
|
Total Shares Repurchased
|
Average Price
Paid Per Share (1) |
Total Shares Purchased As Part Of Publicly Announced Programs
|
Remaining Authorized Share Repurchases
(2)
|
|
January 2, 2016 - January 29, 2016
|
—
|
$—
|
—
|
$113.3 million
|
|
January 30, 2016 - February 26, 2016
|
673,714
|
37.33
|
673,714
|
$88.2 million
|
|
February 27, 2016 - April 1, 2016
|
302,031
|
40.53
|
302,031
|
$75.9 million
|
|
Total
|
975,745
|
|
975,745
|
|
|
(1)
|
Average price paid per share excludes commission costs.
|
|
(2)
|
Amounts represent the approximate dollar value of the maximum remaining number of shares that may yet be purchased under the stock repurchase program, and excludes commission costs.
|
|
Exhibit
Number
|
|
Description
|
|
Incorporated By Reference Herein
|
|
|
||||
|
|
Form
|
|
File Number
|
|
Date
|
|
Filed Herewith
|
|||
|
31.1
|
|
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act
|
|
|
|
|
|
|
|
X
|
|
32.1
‡
|
|
Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
|
|
|
|
|
|
|
|
X
|
|
101.INS
‡
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
X
|
|
101.SCH
‡
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
X
|
|
101.CAL
‡
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
101.DEF
‡
|
|
XBRL Extension Definition
|
|
|
|
|
|
|
|
X
|
|
101.LAB
‡
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
101.PRE
‡
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
DOLBY LABORATORIES, INC.
|
|
|
By:
|
/
S
/ LEWIS CHEW
|
|
|
Lewis Chew
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|